Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-274,658
Closed -$42.8M 42
2024
Q3
$42.8M Buy
274,658
+48,806
+22% +$7.27M 3.17% 17
2024
Q2
$33.4M Buy
225,852
+119,418
+112% +$18.8M 2.4% 19
2024
Q1
$18.9M Buy
+106,434
New +$16.2M 2.13% 21
2021
Q3
Sell
-56,120
Closed -$13.6M 36
2021
Q2
$13.6M Sell
56,120
-47,056
-46% -$10.3M 2.24% 23
2021
Q1
$20.4M Buy
103,176
+13,696
+15% +$2.56M 3.6% 17
2020
Q4
$15.8M Buy
89,480
+15,445
+21% +$2.58M 3.38% 18
2020
Q3
$11.7M Sell
74,035
-45,938
-38% -$6.3M 2.89% 22
2020
Q2
$14.4M Buy
119,973
+25,194
+27% +$2.88M 3.82% 14
2020
Q1
$8.81M Sell
94,779
-11,241
-11% -$1.25M 3.2% 19
2019
Q4
$13.6M Sell
106,020
-11,915
-10% -$1.4M 3.22% 15
2019
Q3
$12.6M Buy
117,935
+1,467
+1% +$140K 2.98% 18
2019
Q2
$10.1M Buy
+116,468
New +$9.41M 2.33% 22

Other funds holding TGT

M.D. Sass LLC's TGT Position: Q4 2024 in Review

M.D. Sass LLC sold out of Target (TGT) in Q4 2024, closing a stake of 274,658 shares — an estimated $42.8M sold.

M.D. Sass LLC first reported a position in TGT in Q2 2019 and held it in 12 quarters. The position peaked at $42.8M in Q3 2024. 1,981 funds tracked by Wall St. Rank hold TGT as of Q4 2024.

  • M.D. Sass LLC reported no remaining Target position as of Q4 2024 after selling out during the quarter.
  • M.D. Sass LLC sold 274,658 Target shares in Q4 2024, an estimated $42.8M.
  • M.D. Sass LLC first reported a position in Target in Q2 2019 and held it in 12 quarters.
  • M.D. Sass LLC's Target position peaked at $42.8M in Q3 2024.
  • 1,981 funds tracked by Wall St. Rank held Target as of Q4 2024.

Based on M.D. Sass LLC's 13F filing for Q4 2024, filed 11 Feb 2025.